Antibody neutralizers of human granulocyte macrophage colony stimulating factor
US-10138297-B2 · Nov 27, 2018 · US
Colony Stimulating Factors
Colony Stimulating Factors · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K16/243 |
| Official title | {Colony Stimulating Factors} |
| Display label | Colony Stimulating Factors |
| Total patents | 149 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 10 |
| 2016 | 20 |
| 2017 | 10 |
| 2018 | 20 |
| 2019 | 8 |
| 2020 | 16 |
| 2021 | 19 |
| 2022 | 11 |
| 2023 | 10 |
| 2024 | 13 |
| 2025 | 10 |
| 2026 | 2 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Antibodies targeting M-CSF
US-10081675-B2 · Sep 25, 2018 · US
Transgenic transchromosomal rodents for making human antibodies
US-10076103-B2 · Sep 18, 2018 · US
Method for the treatment of pain and osteoarthritis with c-fms antagonists
US-2018237531-A1 · Aug 23, 2018 · US
Treatment for rheumatoid arthritis
US-2018230208-A1 · Aug 16, 2018 · US
Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
US-2018222973-A1 · Aug 9, 2018 · US
Compositions and methods for using anti-il-34 antibodies to treat neurological diseases
US-2018222974-A1 · Aug 9, 2018 · US
Liquid formulation comprising gm-csf neutralizing compound
US-2018207278-A1 · Jul 26, 2018 · US
Method for treating cancer metastasis and composition thereof
US-2018194838-A1 · Jul 12, 2018 · US
Method for treatment of osteoarthritis with C-Fms antagonists
US-10005840-B2 · Jun 26, 2018 · US
PD-L1 Antagonist Combination Treatments
US-2018169232-A1 · Jun 21, 2018 · US
Complex-specific antibodies and antibody fragments and its use
US-2018134807-A1 · May 17, 2018 · US
Dual targeting
US-9944719-B2 · Apr 17, 2018 · US
Dual targeting
US-2018094078-A1 · Apr 5, 2018 · US
Liquid formulation comprising GM-CSF neutralizing compound
US-9919051-B2 · Mar 20, 2018 · US
Osteoarthritis treatment
US-2018066062-A1 · Mar 8, 2018 · US
Antibodies targeting m-csf
US-2018057581-A1 · Mar 1, 2018 · US
Inhibition of oncogenic kras-induced GM-CSF production and function
US-9901079-B2 · Feb 27, 2018 · US
Methods and Compositions for the Treatment of Celiac Disease, Non-Celiac Gluten Sensitivity, and Refractory Celiac Disease
US-2018002417-A1 · Jan 4, 2018 · US
Antibodies targeting M-CSF
US-9856316-B2 · Jan 2, 2018 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K16/243?
- CPC C07K16/243 is the Cooperative Patent Classification code for “Colony Stimulating Factors.”
- How many patents are filed under CPC C07K16/243 (Colony Stimulating Factors)?
- Our database includes 149 publications tagged with this CPC code.
- Is patent activity under CPC C07K16/243 growing?
- Publication counts under this code: 13 in 2024 vs 10 in 2025 (latest complete years).